<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a patient with <z:hpo ids='HP_0001510'>growth failure</z:hpo> and multiple congenital anomalies characteristic of Fanconi <z:hpo ids='HP_0001903'>anaemia</z:hpo>, but without the classical feature of progressive <z:hpo ids='HP_0005528'>bone marrow hypoplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Following treatment with growth hormone for a period of 8 years, he presented with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and a karyotypically abnormal clone in the bone marrow (47,XY,+8) </plain></SENT>
<SENT sid="2" pm="."><plain>The diagnosis of Fanconi <z:hpo ids='HP_0001903'>anaemia</z:hpo> was supported by the induction of abnormally high levels of characteristic chromosome aberrations in peripheral lymphocytes following exposure in vitro to the bifunctional <z:chebi fb="0" ids="22333">alkylating agent</z:chebi> <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Immune function studies also identified a selective <z:hpo ids='HP_0002720'>IgA deficiency</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The relative importance of interacting constitutional and exogenous factors involved in the development of <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">preleukaemia</z:e> in this patient is discussed </plain></SENT>
</text></document>